Comments on: Invivodata’s EPRO Solution Captures Primary Efficacy Data Supporting Supplemental Approval Of Sucampo’s AMITIZA For A New Indication

Comments on: Invivodata’s EPRO Solution Captures Primary Efficacy Data Supporting Supplemental Approval Of Sucampo’s AMITIZA For A New Indication http://www.druginformations.org/medicine_news/2008/05/15/invivodatas-epro-solution-captures-primary-efficacy-data-supporting-supplemental-approval-of-sucampos-amitiza-for-a-new-indication/ Your best medicine news resource Sun, 23 Nov 2008 11:24:41 +0000 http://wordpress.org/?v=2.1.2